Prices delayed by at least 15 minutes | Print
Celadon Pharmaceuticals PLC (CEL)
ORD 1POpen
6.50p
Previous close
6.50p
Trade high
7.15p
Volume
7,220
Year high
112.00p
Year low
2.2111p
Dividend yield
–
Market capitalisation
£4.47 mn
P/E ratio
–
ISIN
GB00BDQYGP38
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis. It operates only in the UK and has only one geographical area.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 25/04/2025 | 01:49:14 | 7 | 5 | 0.35 |
| 25/04/2025 | 01:23:23 | 7 | 79 | 5.53 |
| 25/04/2025 | 11:11:17 | 7.15 | 3,000 | 214.50 |
| 25/04/2025 | 09:45:47 | 6.78 | 2,788 | 189.03 |
| 25/04/2025 | 08:32:09 | 7 | 42 | 2.94 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.